Skip to main content Help with accessibility Skip to main navigation

IVACAFTOR (Kalydeco®▼)

CCG Approval Status:

Date Added: 14 - Nov - 2017
Body System:
NHS England

NHS England specialised commissining resources: the clinical reference group responsible for cystic fibrosis has published a commissioning policy that defines access to a particular service for a cohort of patients.